1256 related articles for article (PubMed ID: 30811764)
21. Long non-coding RNA MFSD4A-AS1 promotes lymphangiogenesis and lymphatic metastasis of papillary thyroid cancer.
Liu X; Zhang C; Wang X; Cui C; Cui H; Zhu B; Chen A; Zhang L; Xin J; Fu Q; Dionigi G; Sun H
Endocr Relat Cancer; 2023 Mar; 30(3):. PubMed ID: 36606578
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of serum lncRNA-ABHD11-AS1 as poor prognosis of patients with papillary thyroid carcinoma.
Hou S; Zhuang YY; Lin QY; Chen Z; Zhao HG; Zhang L; Lin CH
Exp Mol Pathol; 2021 Aug; 121():104658. PubMed ID: 34102210
[TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNA AGAP2-AS1 promotes proliferation and metastasis in papillary thyroid cancer by miR-628-5p/KLF12 axis.
Xu C; Shao Y; Liu J; Yao X; Quan F; Zhao Q; Zhao R; Kou B; Li H; Han P; Wang X; Bai Y; Zheng Z; Zhang S
J Bioenerg Biomembr; 2021 Apr; 53(2):235-245. PubMed ID: 33604734
[TBL] [Abstract][Full Text] [Related]
24. LncRNA HOXA-AS2 Facilitates Tumorigenesis and Progression of Papillary Thyroid Cancer by Modulating the miR-15a-5p/HOXA3 Axis.
Jiang L; Wu Z; Meng X; Chu X; Huang H; Xu C
Hum Gene Ther; 2019 May; 30(5):618-631. PubMed ID: 30375256
[TBL] [Abstract][Full Text] [Related]
25. Altered expression of DLG1-AS1 distinguished papillary thyroid carcinoma from benign thyroid nodules.
He T; Wang H; Sun J; Wu J; Gong F; Li S; Wang H; Li Y
BMC Endocr Disord; 2019 Nov; 19(1):122. PubMed ID: 31718630
[TBL] [Abstract][Full Text] [Related]
26. Long non-coding RNA OIP5-AS1 serves as a competing endogenous RNA to modulate X-linked inhibitor of apoptosis protein expression via adsorbing miR-429 in papillary thyroid cancer.
Yu CS; Wang YB; Li Q; Yang EL; Dong BB
J Biol Regul Homeost Agents; 2021; 35(3):909-920. PubMed ID: 34155880
[TBL] [Abstract][Full Text] [Related]
27. LncRNA TTN-AS1 promotes migration, invasion, and epithelial mesenchymal transition of lung adenocarcinoma via sponging miR-142-5p to regulate CDK5.
Jia Y; Duan Y; Liu T; Wang X; Lv W; Wang M; Wang J; Liu L
Cell Death Dis; 2019 Jul; 10(8):573. PubMed ID: 31363080
[TBL] [Abstract][Full Text] [Related]
28. LncRNA XIST Promotes Migration and Invasion of Papillary Thyroid Cancer Cell by Modulating MiR-101-3p/CLDN1 Axis.
Du YL; Liang Y; Cao Y; Liu L; Li J; Shi GQ
Biochem Genet; 2021 Apr; 59(2):437-452. PubMed ID: 33057875
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-26a suppresses the malignant biological behaviors of papillary thyroid carcinoma by targeting ROCK1 and regulating PI3K/AKT signaling pathway.
Wu YC; Li SY; Jia YF
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8940-8949. PubMed ID: 31696481
[TBL] [Abstract][Full Text] [Related]
30. lncRNA DUXAP8 inhibits papillary thyroid carcinoma cell apoptosis via sponging the miR‑20b‑5p/SOS1 axis.
Pang R; Yang S
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760128
[TBL] [Abstract][Full Text] [Related]
31. LncRNA TTN-AS1/miR-134-5p/PAK3 axis regulates the radiosensitivity of human large intestine cancer cells through the P21 pathway and AKT/GSK-3β/β-catenin pathway.
Zuo Z; Ji S; He L; Zhang Y; Peng Z; Han J
Cell Biol Int; 2020 Nov; 44(11):2284-2292. PubMed ID: 32749739
[TBL] [Abstract][Full Text] [Related]
32. Long noncoding RNA LINC00520 accelerates progression of papillary thyroid carcinoma by serving as a competing endogenous RNA of microRNA-577 to increase Sphk2 expression.
Sun Y; Shi T; Ma Y; Qin H; Li K
Cell Cycle; 2020 Apr; 19(7):787-800. PubMed ID: 32075502
[TBL] [Abstract][Full Text] [Related]
33. LncRNA PROX1-AS1 promotes proliferation, invasion, and migration in papillary thyroid carcinoma.
Shen Y; Xia E; Bhandari A; Wang X; Guo G
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30061172
[TBL] [Abstract][Full Text] [Related]
34. Long noncoding RNA TTN-AS1 promotes the proliferation and migration of prostate cancer by inhibiting miR-1271 level.
Zhu Y; Yang Z; Luo XH; Xu P
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10678-10684. PubMed ID: 31858535
[TBL] [Abstract][Full Text] [Related]
35. TTN-AS1 delivered by gastric cancer cell-derived exosome induces gastric cancer progression through in vivo and in vitro studies.
Wang Y; Jiang R; Zhao H; Li F; Li Y; Zhu M
Cell Biol Toxicol; 2023 Apr; 39(2):557-571. PubMed ID: 36214926
[TBL] [Abstract][Full Text] [Related]
36. LncRNA CCND2-AS1 promotes proliferation, migration, and invasion in papillary thyroid carcinoma.
Xia E; Bhandari A; Shen Y; Zhou X; Sindan N; Xiang J; Guan Y; Yang F; Wang O
Biochem Biophys Res Commun; 2018 Feb; 496(2):628-632. PubMed ID: 29366479
[TBL] [Abstract][Full Text] [Related]
37. LncRNA RHPN1-AS1 Promotes Cell Proliferation, Migration and Invasion Through Targeting miR-7-5p and Activating PI3K/AKT/mTOR Pathway in Hepatocellular Carcinoma.
Song XZ; Ren XN; Xu XJ; Ruan XX; Wang YL; Yao TT
Technol Cancer Res Treat; 2020; 19():1533033820957023. PubMed ID: 32910747
[TBL] [Abstract][Full Text] [Related]
38. LncRNA FAM230B promotes the metastasis of papillary thyroid cancer by sponging the miR-378a-3p/WNT5A axis.
Zhou Q; Feng J; Yin S; Ma S; Wang J; Yi H
Biochem Biophys Res Commun; 2021 Mar; 546():83-89. PubMed ID: 33578293
[TBL] [Abstract][Full Text] [Related]
39. LncRNA LINC00460 promotes the papillary thyroid cancer progression by regulating the LINC00460/miR-485-5p/Raf1 axis.
Li G; Kong Q
Biol Res; 2019 Dec; 52(1):61. PubMed ID: 31870440
[TBL] [Abstract][Full Text] [Related]
40. LncRNA GAS8-AS1 suppresses papillary thyroid carcinoma cell growth through the miR-135b-5p/CCND2 axis.
Chen N; Yin D; Lun B; Guo X
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30429236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
